Related Experiment Video
Updated: Jul 18, 2026
08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Allergic contact dermatitis to pimecrolimus.
Peter Saitta1, Ronald Brancaccio
1School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey, Stratford 08024, NJ, USA.
Contact Dermatitis
|December 21, 2006
Summary
Pimecrolimus effectively reduces inflammatory cytokine production from skin cells. This makes it a key treatment for atopic dermatitis, commonly known as eczema.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Atopic dermatitis is a chronic inflammatory skin condition.
- Current treatments aim to manage inflammation and immune responses.
- Pimecrolimus is a topical immunomodulator.
Observation:
- Pimecrolimus targets the production of pro-inflammatory cytokines.
- It specifically affects cutaneous T cells and mast cells.
- This suppression reduces the inflammatory cascade in the skin.
Findings:
- Pimecrolimus inhibits the release of key inflammatory mediators.
- This action is crucial for managing the symptoms of atopic dermatitis.
- The drug is formulated as a 1.0% topical cream.
Implications:
- Pimecrolimus offers a targeted approach to managing atopic dermatitis.
- Understanding its mechanism aids in developing new immunomodulatory therapies.
- This agent provides a non-steroidal option for patients with eczema.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
02:06Allergic Reactions
Overview
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...